Next Vial scores 59/100 (grade C, ranked #389) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Marek Health is a performance-focused telehealth platform pairing US clients with partnered physicians and health coaches for GLP-1 weight-loss therapy (semaglutide and tirzepatide), comprehensive lab…
Joey Med is a Tampa, FL telehealth platform offering injectable GLP-1 weight-loss treatments alongside sexual health, longevity, hair-growth, and travel-wellness products — a multi-vertical model for…
Joey Med matches Next Vial at 59/100; the full Joey Med review has the pricing conditions and the caveats in detail.
SkyRx is a US telehealth weight-loss program offering compounded semaglutide as an injection or oral drops, with compounded tirzepatide listed as coming soon.
SkyRx matches Next Vial at 59/100; our full write-up on SkyRx has the pricing conditions and the caveats in detail.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.